Jim Bianco, Founder and President of Bianco Research, on his current market outlook. Crystal Tse, Bloomberg IPO reporter, on the new SPAC barons, from Bill Ackman to Billy Beane. Timothy O'Brien, Senior Columnist for Bloomberg Opinion, on his column: "Of Course Trump Couldn’t Resist Bob Woodward." Lauren Sauer, Johns Hopkins University Assistant Professor of Emergency Medicine, on the coronavirus: flu season, AstraZeneca vaccine trial pause, and the China vaccine. Hosted by Paul Sweeney and Vonnie Quinn. 

Jim Bianco, Founder and President of Bianco Research, on his current market outlook. Crystal Tse, Bloomberg IPO reporter, on the new SPAC barons, from Bill Ackman to Billy Beane. Timothy O'Brien, Senior Columnist for Bloomberg Opinion, on his column: "Of Course Trump Couldn’t Resist Bob Woodward." Lauren Sauer, Johns Hopkins University Assistant Professor of Emergency Medicine, on the coronavirus: flu season, AstraZeneca vaccine trial pause, and the China vaccine. Hosted by Paul Sweeney and Vonnie Quinn.

Listen for investment news and in-depth company research. 

Hosts Paul Sweeney and Scarlet Fu harness the power of Bloomberg Intelligence to analyze investments on Wall Street. Watch Bloomberg Intelligence LIVE on YouTube, weekdays from 10AM to 12PM ET: http://bit.ly/3vTiACF.

Listen for investment news and in-depth company research. Hosts Paul Sweeney and Scarlet Fu harness the power of Bloomberg Intelligence to analyze investments on Wall Street. Watch Bloomberg Intelligence LIVE on YouTube, weekdays from 10AM to 12PM ET: <a href="http://bit.ly/3vTiACF">http://bit.ly/3vTiACF</a>.

Alix Steel and Paul Sweeney harness the power of Bloomberg Intelligence to analyze markets, companies and industries.

Bloomberg Intelligence

"We're Halfway There" to 10-15% Correction: Jim Bianco

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/ddbdbebe-6f1f-4214-b0eb-ae3c003c57cf/transcript

Watch Scarlet and Paul LIVE every day on YouTube: http://bit.ly/3vTiACF.

Bloomberg Intelligence hosted by Paul Sweeney and Scarlet Fu

- David Welch, Bloomberg Detroit Bureau Chief, discusses Tesla sales. Tesla Inc. posted one of its worst sales quarters in years, missing Wall Street’s expectations, as the carmaker struggles to turn around its core business and navigate an increasingly challenged electric-vehicle market.
Separately, Stellantis is discussing options for building electric vehicles in Canada with its Chinese partner, Zhejiang Leapmotor Technology Co. The talks are in an early stage and focused on an idled Stellantis assembly plant in Brampton, Ontario, with the possibility of building cars in partnership with Leapmotor.

- Brody Ford, Bloomberg Technology Reporter, discusses the Bloomberg Big Take story “Microsoft CFO’s AI Spending Runs Up Against Tech Bubble Fears.”
Description:
Microsoft Chief Financial Officer Amy Hood must decide how much to spend on artificial intelligence without starving other parts of the company or alarming Wall Street. In this executive profile, Bloomberg exclusively reports that Hood made the call to pause data center construction last year, a controversial decision some say left the company without enough computing power for its AI services.

- Robert Schiffman, Senior Tech Credit Analyst for Bloomberg Intelligence, discusses how Intel’s turnaround is advancing as spending is cut.
According to Bloomberg Intelligence: Intel's new CEO is stabilizing the company's credit profile, refocusing core-product franchises and cutting costs. It's still a work in progress, but reductions in operating expenses and capital spending are paying off, enabling Intel to buy back a $14.2 billion stake in its Ireland fabrication joint venture without jeopardizing its investment grade profile.

Watch Scarlet and Paul LIVE every day on YouTube: <a href="http://bit.ly/3vTiACF">http://bit.ly/3vTiACF</a>. Bloomberg Intelligence hosted by Paul Sweeney and Scarlet Fu - David Welch, Bloomberg Detroit Bureau Chief, discusses Tesla sales. Tesla Inc. posted one of its worst sales quarters in years, missing Wall Street&rsquo;s expectations, as the carmaker struggles to turn around its core business and navigate an increasingly challenged electric-vehicle market. Separately, Stellantis is discussing options for building electric vehicles in Canada with its Chinese partner, Zhejiang Leapmotor Technology Co. The talks are in an early stage and focused on an idled Stellantis assembly plant in Brampton, Ontario, with the possibility of building cars in partnership with Leapmotor. - Brody Ford, Bloomberg Technology Reporter, discusses the Bloomberg Big Take story &ldquo;Microsoft CFO&rsquo;s AI Spending Runs Up Against Tech Bubble Fears.&rdquo; Description: Microsoft Chief Financial Officer Amy Hood must decide how much to spend on artificial intelligence without starving other parts of the company or alarming Wall Street. In this executive profile, Bloomberg exclusively reports that Hood made the call to pause data center construction last year, a controversial decision some say left the company without enough computing power for its AI services. - Robert Schiffman, Senior Tech Credit Analyst for Bloomberg Intelligence, discusses how Intel&rsquo;s turnaround is advancing as spending is cut. According to Bloomberg Intelligence: Intel's new CEO is stabilizing the company's credit profile, refocusing core-product franchises and cutting costs. It's still a work in progress, but reductions in operating expenses and capital spending are paying off, enabling Intel to buy back a $14.2 billion stake in its Ireland fabrication joint venture without jeopardizing its investment grade profile.

Tesla’s EV Sales Miss Expectations Again in Deepening Slump 

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/ebc2e8ff-30e6-427a-ade8-b420010f06a9/transcript

Watch Scarlet and Paul LIVE every day on YouTube: http://bit.ly/3vTiACF.

Bloomberg Intelligence hosted by Paul Sweeney and Scarlet Fu

- Anthony Hughes, Bloomberg US Equity Capital Markets Reporter, discusses SpaceX  filing confidentially for an initial public offering, bringing the company closer to delivering the biggest-ever listing. The company submitted its draft IPO registration to the US Securities and Exchange Commission and could seek a valuation in the IPO of more than $1.75 trillion.

-Lily Meier, Bloomberg Retail Reporter, discusses Nike earnings. Nike Inc. shares fell after the company gave a gloomy outlook for the year ahead, with revenue expected to decline 2% to 4% in the current quarter. The company is facing headwinds around the globe, including elevated inventories in Europe and the Middle East and weakness in Greater China and other areas.

-Lindsay Dutch, Bloomberg Intelligence Consumer Hardlines Senior Analyst, recaps earnings from RH. RH shares plunged after the home furnishing company forecast revenue for the first quarter that missed the average analyst estimate.

Watch Scarlet and Paul LIVE every day on YouTube: <a href="http://bit.ly/3vTiACF">http://bit.ly/3vTiACF</a>. Bloomberg Intelligence hosted by Paul Sweeney and Scarlet Fu - Anthony Hughes, Bloomberg US Equity Capital Markets Reporter, discusses SpaceX &nbsp;filing confidentially for an initial public offering, bringing the company closer to delivering the biggest-ever listing. The company submitted its draft IPO registration to the US Securities and Exchange Commission and could seek a valuation in the IPO of more than $1.75 trillion. -Lily Meier, Bloomberg Retail Reporter, discusses Nike earnings. Nike Inc. shares fell after the company gave a gloomy outlook for the year ahead, with revenue expected to decline 2% to 4% in the current quarter. The company is facing headwinds around the globe, including elevated inventories in Europe and the Middle East and weakness in Greater China and other areas. -Lindsay Dutch, Bloomberg Intelligence Consumer Hardlines Senior Analyst, recaps earnings from RH. RH&nbsp;shares plunged after the home furnishing company forecast revenue for the first quarter that missed the average analyst estimate.

SpaceX Said to File Confidentially for IPO Before AI Rivals 

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/da5abe7b-4f96-4bae-9697-b42000f5ac22/transcript

Watch Scarlet and Paul LIVE every day on YouTube: http://bit.ly/3vTiACF.

Bloomberg Intelligence hosted by Paul Sweeney and Scarlet Fu

-Diana Gomes, Bloomberg Intelligence Senior Equity Analyst, discusses Unilever agreeing to combine its food business with McCormick & Co. in a $44.8 billion deal that will create a global seasonings, sauces and condiments company. Under the agreement, McCormick will pay $15.7 billion in cash and the equivalent of $29.1 billion in shares for most of Unilever’s food business, leaving Unilever with 65% of the combined entity.

-Sam Fazeli, Bloomberg Intelligence, Director of Research for Global Industries and Senior Pharmaceuticals Analyst, discusses the latest M&A in the biotech sector. Eli Lilly & Co. agreed to buy Centessa Pharmaceuticals Plc in a deal worth up to $7.8 billion to bulk up its treatment pipeline for other conditions.
Biogen Inc. has agreed to acquire Apellis Pharmaceuticals Inc. for $5.6 billion, expanding its treatments in immunology and rare diseases.

-Mandeep Singh, Global Tech Research Head at Bloomberg Intelligence, discusses Nvidia taking a $2 billion stake in Marvell Technology. It is opening up its system to allow Marvell to integrate custom artificial intelligence chips and networking equipment on the platform.

-Hannah Levitt, Bloomberg Senior Finance Reporter, discusses JPMorgan Chase announcing the "American Dream Initiative" to expand economic opportunity in local communities across the country, spanning six focus areas including small businesses, housing and financial health.

Watch Scarlet and Paul LIVE every day on YouTube: <a href="http://bit.ly/3vTiACF" data-destination="rte:bind">http://bit.ly/3vTiACF</a>. Bloomberg Intelligence hosted by Paul Sweeney and Scarlet Fu -Diana Gomes, Bloomberg Intelligence Senior Equity Analyst, discusses Unilever agreeing to combine its food business with McCormick &amp; Co. in a $44.8 billion deal that will create a global seasonings, sauces and condiments company. Under the agreement, McCormick will pay $15.7 billion in cash and the equivalent of $29.1 billion in shares for most of Unilever&rsquo;s food business, leaving Unilever with 65% of the combined entity. -Sam Fazeli, Bloomberg Intelligence, Director of Research for Global Industries and Senior Pharmaceuticals Analyst, discusses the latest M&amp;A in the biotech sector. Eli Lilly &amp; Co. agreed to buy Centessa Pharmaceuticals Plc in a deal worth up to $7.8 billion to bulk up its treatment pipeline for other conditions. Biogen Inc. has agreed to acquire Apellis Pharmaceuticals Inc. for $5.6 billion, expanding its treatments in immunology and rare diseases. -Mandeep Singh, Global Tech Research Head at Bloomberg Intelligence, discusses Nvidia taking a $2 billion stake in Marvell Technology. It is opening up its system to allow Marvell to integrate custom artificial intelligence chips and networking equipment on the platform. -Hannah Levitt, Bloomberg Senior Finance Reporter, discusses JPMorgan Chase announcing the "American Dream Initiative" to expand economic opportunity in local communities across the country, spanning six focus areas including small businesses, housing and financial health.

 Unilever Food Arm to Join McCormick in $44.8 Billion Deal 

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/e61f01f3-83ee-46a1-9374-b41e0111cfe4/transcript

"We're Halfway There" to 10-15% Correction: Jim Bianco

In 1 playlist(s)

Bloomberg Intelligence

Social links

Follow podcast

Recent clips